X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32476) 32476
Newsletter (3847) 3847
Publication (1794) 1794
Book Review (368) 368
Magazine Article (178) 178
Book Chapter (91) 91
Book / eBook (88) 88
Newspaper Article (61) 61
Conference Proceeding (45) 45
Trade Publication Article (36) 36
Web Resource (36) 36
Dissertation (20) 20
Journal / eJournal (8) 8
Paper (7) 7
Reference (5) 5
Data Set (2) 2
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26718) 26718
thrombolytic therapy (21592) 21592
male (14314) 14314
female (13397) 13397
middle aged (11340) 11340
aged (10458) 10458
index medicus (8351) 8351
treatment outcome (7075) 7075
cardiac & cardiovascular systems (6459) 6459
thrombolytic drugs (6001) 6001
thrombolytic therapy - methods (5832) 5832
myocardial infarction - drug therapy (5469) 5469
adult (5393) 5393
fibrinolytic agents - therapeutic use (5273) 5273
stroke (5057) 5057
thrombolysis (4932) 4932
time factors (4932) 4932
peripheral vascular disease (4810) 4810
tissue plasminogen activator - therapeutic use (4307) 4307
clinical neurology (4007) 4007
myocardial infarction - therapy (3952) 3952
aged, 80 and over (3793) 3793
risk factors (3783) 3783
care and treatment (3522) 3522
research (3234) 3234
stroke - drug therapy (3141) 3141
retrospective studies (3044) 3044
therapy (3022) 3022
mortality (2987) 2987
thrombolytic therapy - adverse effects (2777) 2777
medicine, general & internal (2769) 2769
fibrinolytic agents - administration & dosage (2736) 2736
acute myocardial-infarction (2712) 2712
prognosis (2664) 2664
myocardial infarction - mortality (2561) 2561
heart attack (2540) 2540
acute disease (2501) 2501
electrocardiography (2448) 2448
tissue plasminogen activator - administration & dosage (2377) 2377
thrombosis (2335) 2335
myocardial infarction (2292) 2292
prospective studies (2259) 2259
acute ischemic-stroke (2250) 2250
surgery (2243) 2243
angioplasty, balloon, coronary (2231) 2231
animals (2053) 2053
management (2045) 2045
trial (2034) 2034
follow-up studies (2033) 2033
tissue-plasminogen activator (2021) 2021
drug therapy (2002) 2002
myocardial infarction - physiopathology (1941) 1941
angioplasty (1891) 1891
tissue plasminogen activator (1854) 1854
reperfusion (1839) 1839
reports (1832) 1832
anticoagulants - therapeutic use (1826) 1826
ischemia (1798) 1798
drugs (1715) 1715
myocardial infarction - diagnosis (1706) 1706
stroke - therapy (1681) 1681
brain ischemia - drug therapy (1678) 1678
coronary angiography (1648) 1648
universities and colleges (1633) 1633
streptokinase - therapeutic use (1628) 1628
streptokinase (1578) 1578
analysis (1551) 1551
hematology (1548) 1548
fibrinolytic agents - adverse effects (1543) 1543
health aspects (1506) 1506
fibrinolysis (1488) 1488
neurosciences (1484) 1484
tomography, x-ray computed (1445) 1445
recurrence (1419) 1419
cardiology (1408) 1408
heart attacks (1391) 1391
medical research (1379) 1379
thrombosis - drug therapy (1376) 1376
alteplase (1368) 1368
radiology, nuclear medicine & medical imaging (1356) 1356
stents (1321) 1321
anticoagulants (1261) 1261
stroke - diagnosis (1260) 1260
pulmonary embolism (1242) 1242
combined modality therapy (1227) 1227
tissue plasminogen activator - adverse effects (1211) 1211
urokinase-type plasminogen activator - therapeutic use (1208) 1208
cardiac patients (1207) 1207
randomized controlled trials as topic (1198) 1198
heparin - therapeutic use (1197) 1197
acute myocardial infarction (1187) 1187
myocardial infarction - complications (1181) 1181
risk (1180) 1180
medicine, experimental (1173) 1173
abridged index medicus (1163) 1163
usage (1160) 1160
diagnosis (1133) 1133
medicine & public health (1131) 1131
tissue-plasminogen-activator (1112) 1112
neurology (1110) 1110
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (55) 55
Online Resources - Online (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Periodical Stacks (2) 2
Scarborough Hospital - General (2) 2
Toronto East General Hospital - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32067) 32067
German (1233) 1233
French (600) 600
Spanish (555) 555
Japanese (404) 404
Italian (372) 372
Russian (354) 354
Chinese (238) 238
Portuguese (150) 150
Polish (145) 145
Norwegian (101) 101
Danish (95) 95
Swedish (86) 86
Czech (83) 83
Dutch (63) 63
Hungarian (63) 63
Turkish (59) 59
Korean (30) 30
Finnish (26) 26
Hebrew (22) 22
Serbian (20) 20
Croatian (17) 17
Slovak (17) 17
Icelandic (9) 9
Lithuanian (6) 6
Romanian (6) 6
Ukrainian (5) 5
Persian (4) 4
Slovenian (3) 3
Bulgarian (2) 2
Arabic (1) 1
Bosnian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e669S - e690S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e1S - e23S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e576S - e600S
Background: Antithrombotic therapy in valvular disease is important to mitigate thromboembolism, but the hemorrhagic risk imposed must be considered. Methods:... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heart Valve Diseases - blood | Mitral Valve | Thrombosis - complications | Ductus Arteriosus, Patent - drug therapy | Humans | Postoperative Complications - blood | Postoperative Complications - prevention & control | Stroke - complications | Hemorrhage - prevention & control | Rheumatic Heart Disease - blood | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Ductus Arteriosus, Patent - blood | Thromboembolism - prevention & control | Aspirin - adverse effects | Heart Valve Diseases - complications | Fibrinolytic Agents - therapeutic use | Rheumatic Heart Disease - drug therapy | Rheumatic Heart Disease - complications | Aspirin - therapeutic use | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Thrombosis - blood | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Catheterization | Heart Atria | Heart Valve Prosthesis | Risk Factors | Ductus Arteriosus, Patent - complications | Combined Modality Therapy | Evidence-Based Medicine | Stroke - blood | Thromboembolism - blood | Heart Valve Diseases - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods: We... 
HIGH-RISK PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | CEREBRAL VENOUS THROMBOSIS | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | LONG-TERM SURVIVAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | ASPIRIN PLUS DIPYRIDAMOLE | NONVALVULAR ATRIAL-FIBRILLATION | EXTENDED-RELEASE DIPYRIDAMOLE | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Book
1990, ISBN 0702014745, Volume 3/no. 3., x, p. 483-836.
Book
1988, ISBN 9780808918912, xii, 306
Book
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 5, pp. 815 - 821.e6
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 9, pp. 962 - 969
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2001, Volume 357, Issue 9272, pp. 1905 - 1914
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 01/2009, Volume 40, Issue 1, pp. 140 - 146
Background and Purpose-While intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute stroke therapy within 3 hours, the... 
Vertrobrobasilary disease | Abciximab | Acute stroke | Emergency medicine | Neurocritial care | Stents | Thrombolysis | Antiplatelet agents | Interventional neuroradiology | INTRAVENOUS ABCIXIMAB | antiplatelet agents | MULTICENTER | emergency medicine | THROMBOSIS | stents | RECANALIZATION | interventional neuroradiology | vertrobrobasilary disease | CLINICAL NEUROLOGY | TRIAL | FIBRINOLYSIS | CHOICE | INFARCTION | acute stroke | neurocritial care | abciximab | DISEASE | thrombolysis | PERIPHERAL VASCULAR DISEASE | ISCHEMIC-STROKE | Infusions, Intra-Arterial - statistics & numerical data | Outcome Assessment (Health Care) - methods | Infusions, Intra-Arterial - standards | Prospective Studies | Recovery of Function - drug effects | Humans | Middle Aged | Male | Young Adult | Vertebrobasilar Insufficiency - drug therapy | Vertebrobasilar Insufficiency - mortality | Platelet Aggregation Inhibitors - administration & dosage | Thrombolytic Therapy - methods | Aged, 80 and over | Recovery of Function - physiology | Adult | Female | Thrombolytic Therapy - standards | Infusions, Intra-Arterial - methods | Basilar Artery - drug effects | Vertebrobasilar Insufficiency - pathology | Thrombolytic Therapy - statistics & numerical data | Survival Rate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Radiography | Diagnostic Imaging | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Basilar Artery - pathology | Injections, Intravenous - methods | Aged | Basilar Artery - diagnostic imaging | Fibrinolytic Agents - administration & dosage | Injections, Intravenous - standards | Injections, Intravenous - statistics & numerical data
Journal Article
2007, 1st ed., ISBN 0470319380, xiv, 350 p., [4] p. of plates
Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute... 
Cardiovascular Disease | Medical / Cardiology | Treatment | Thrombosis | Fibrinolytic agents | Thrombolytic therapy
Book
Journal Article